Marpai, Inc. reports recurring developments in healthcare technology, third-party administration and pharmacy benefit management services for employers that directly fund employee health benefits. The company operates subsidiaries that provide TPA, PBM and value-oriented health plan services, including the MarpaiRx pharmacy benefit platform and the Marpai Saves initiative.
News about MRAI commonly covers MarpaiRx client wins, marketing collaborations, network access arrangements with providers such as Aetna and Cigna, financial results, operating efficiency initiatives and leadership changes tied to its health benefits administration business.
Marpai, Inc. (Nasdaq: MRAI) has priced its initial public offering (IPO) at $4.00 per share, raising gross proceeds of $25 million through the sale of 6,250,000 shares. An additional 937,500 shares may be purchased by underwriters to cover over-allotments. The shares are set to trade on the Nasdaq Capital Market starting October 27, 2021, with the offering closing on October 29, 2021. Marpai utilizes deep learning technology to transform third-party administration in the healthcare self-funded market, serving over 40,000 members across the U.S.